MC2 Therapeutics
is headquartered in Hørsholm, Capital Region. Jesper J Lange is the President & CEO of MC2 Therapeutics. MC2 Therapeutics has 1 followers on Owler.MC2 Therapeutics
is headquartered in Hørsholm, Capital Region. Jesper J Lange is the President & CEO of MC2 Therapeutics. MC2 Therapeutics has 1 followers on Owler.
Est. Annual Revenue
<$1M
Est. Employees
<10
News
Nov 15, 2024
centralcharts
Press Release: MC2 Therapeutics : Endo Announces Agreement for Paladin Pharma to Commercialize Wynzora Cream in Canada
May 13, 2024
FinanzNachrichten
MC2 Therapeutics: MC2 Therapeutics Receives Positive Feedback from FDA pre-IND Meeting and Updates on Indication Expansion Strategy
Feb 26, 2024
Benzinga
MC2 Therapeutics: MC2 Therapeutics to Present at Upcoming Conferences
Dec 07, 2023
GlobalNewswire
Press Release: MC2 Therapeutics : MC2 Therapeutics Announces Completion of Enrollment in MC2-25 Ph2 Chronic Kidney Disease-associated Pruritus Trial
Nov 25, 2023
Pharmabiz
MC2 Therapeutics: MC2 Therapeutics begins patient enrolment in phase 2 PoC of MC225 VLS to treat Vulvar Lichen Sclerosus
Oct 17, 2023
Global Legal Chronicle
MC2 Therapeutics: Hangzhou Zhongmei Huadong Pharmaceutical Co..'s Licensing Agreement with Arcutis Biotherapeutic
Oct 11, 2023
Endpoints News
MC2 Therapeutics: MC2 Therapeutics gears up for Phase IIb hidradenitis suppurativa trial following early clinical results
Apr 28, 2023
Medthority
MC2 Therapeutics: Publication of Psoriasis Patient Data demonstrating need for rapid symptom improvement
Sep 16, 2022
Medthority
MC2 Therapeutics: EPI Health, a Novan Company, and MC2 Therapeutics present Wynzora cream, 0.005%/0.064% subgroup data analysis at Skin of Color Update 2022 Conference.
Sep 16, 2022
Pharmabiz
MC2 Therapeutics: MC2 Therapeutics begins patient dosing in European phase 2 trial in CKDaP